Department of Plastic Surgery, Hand Surgery and Burn Center, University Hospital RWTH Aachen
Aachen, 52074, Germany
NCT Number: NCT01884376
The aim of this study is the development and initial clinical application of the nerve guide Neuromaix in humans to provide evidence for the safety and performance of the device.
Neuromaix is intended to be used as a guiding structure to bridge a peripheral nerve discontinuity, and to create a conduit for axonal growth across the nerve gap.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Aachen, 52074, Germany
The Neuromaix nerve guide is an absorbable implant composed of porcine collagen, used to bridge a peripheral nerve discontinuity, and to create a conduit for axonal growth across the nerve gap. Neuromaix provides a protective environment for peripheral nerve regeneration after injury. Neuromaix connects the proximal and distal ends of a transected nerve, allowing regenerating axons to grow through the scaffold, into the distal nerve tissue towards the target muscle or skin.
Neuromaix is composed of two parts. The Epimaix part provides the structural characteristics needed to suture the nerve guide in place and to prevent ingrowth of scar tissue. The Perimaix part provides a structure that mimics endoneurial tubes, providing guidance for the regenerating axons while bridging the nerve gap.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
The primary objective is the proof of safety of the medical device Neuromaix. key parameter: normal wound healing without complications
Time frame: 12 months
The secondary objective is the evaluation of the effectiveness of the Neuromaix implantation ("Performance arm of study").
key parameters: axonal regeneration and recovery of sensory function
RWTH Aachen University
Other
Klinische Interventionsstrategie Zur überbrückenden Behandlung Peripherer Nervendefekte Mit Neuromaix
Acronym: PeRepair
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03970655
Chronic Rhinosinusitis (Diagnosis), Disease
Gainesville, Florida, United States
View Trial DetailsNCT07731217
Asthma, Asthma (Diagnosis)
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02328963
Cytomegalovirus Infection, Cytomegalovirus Infections
Bordeaux, France
View Trial DetailsNCT05468619
DNA Virus Infections, Disease
Birmingham, Alabama, United States
View Trial Details